ID
ZBH icon

Integral Derivatives’s Zimmer Biomet ZBH Stock Holding History

Integral Derivatives’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-8,137
Closed -$742K – 1258
2015
Q3 		$742K Sell
8,137
-7,416
-48% -$743K 0.02% 602
2015
Q2 		$1.65M Buy
15,553
+5,150
+50% +$570K 0.05% 378
2015
Q1 		$1.19M Hold
10,403
– – 0.02% 457
2014
Q4 		$1.15M Buy
10,403
+103
+1% +$10.9K 0.02% 622
2014
Q3 		$1.01M Buy
+10,300
New +$1.01M 0.02% 709

Other funds holding ZBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Integral Derivatives's ZBH Position: Q4 2015 in Review

Integral Derivatives sold out of Zimmer Biomet (ZBH) in Q4 2015, closing a stake of 3,068 shares — an estimated $280K sold.

Integral Derivatives first reported a position in ZBH in Q3 2014 and held it in 5 quarters. The position peaked at $616K in Q3 2014. 740 funds tracked by Wall St. Rank hold ZBH as of Q4 2015.

  • Integral Derivatives reported no remaining Zimmer Biomet position as of Q4 2015 after selling out during the quarter.
  • Integral Derivatives sold 3,068 Zimmer Biomet shares in Q4 2015, an estimated $280K.
  • Integral Derivatives first reported a position in Zimmer Biomet in Q3 2014 and held it in 5 quarters.
  • Integral Derivatives's Zimmer Biomet position peaked at $616K in Q3 2014.
  • 740 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2015.

Based on Integral Derivatives's 13F filing for Q4 2015, filed 22 Jan 2016.